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Purpose: Earlier studies have revealed a decreased level of cGMP in vitreous fluid obtained from patients with a retinal
detachment. To further investigate this phenomenon, we developed an experimental retinal detachment model in pigs.
Methods: Experimental unilateral retinal detachments were induced in pig eyes by subretinal injection of 0.25% sodium
hyaluronate. Fourteen days later the vitreous and retinas were analyzed for cGMP expression. Following enucleation, the
retinas were incubated in the presence of a nonselective phosphodiesterase inhibitor (IBMX), and the particulate guanylyl
cyclase stimulator atrial natriuretic peptide (ANP) or the soluble guanylyl cyclase stimulator sodium nitroprusside (SNP).
cGMP was visualized in retinal wholemounts by immunochemistry combined with a computer based stereology system.
cGMP levels in vitreous were determined by ELISA.
Results: The mean vitreous cGMP level in pig eyes with a retinal detachment (1.45 pmol/ml) was significantly lower
compared to the mean level of cGMP in healthy pig eyes (4.61 pmol/ml; p=0.028 was considered significant). In the inner
retina, ANP as well as SNP induced cGMP immunoreactivity in both detached and healthy retinas. After incubation with
ANP, cGMP could also be detected in the outer nuclear layer of the detached retina, whereas this was not the case in the
normal retina.
Conclusions: Experimental retinal detachment in the pig eye leads to a decrease of cGMP levels in vitreous similar to
that observed in clinical studies. This model may be helpful to analyze the mechanisms involved in cGMP dynamics
following retinal detachment.
A retinal detachment is defined as a break between the
photoreceptor layer and the retinal pigment epithelium (RPE),
whereby  the  formed  space  is  filled  with  fluid.  A  retinal
detachment  can  cause  serious  visual  impairment  of  the
affected eye, depending, among other factors, upon the time
interval  between  the  initial  detachment  and  the  surgical
reattachment [1]. Even though surgical repair of the detached
retina is often anatomically successful, the affected eye rarely
regains  its  original  acuity  [2-4].  This  may  be  due  to
irreversible damage to the retina, caused by hypoxia as well
as  ischemia  of  retinal  cells,  such  as  the  photoreceptor  or
Müller cells [4,5]. To analyze the damage to photoreceptor
cells,  we  began  studies  to  investigate  the  level  of  cyclic
guanosine monophosphate (cGMP) in the surrounding fluids
[6]. cGMP was chosen as a marker since it is an important
molecule in the metabolic cascade of photoreceptor signal
transduction.  The  production  of  cGMP  is  catalyzed  by
guanylyl cyclases (GCs), which are found in photoreceptor
cells [7] and inner retinal neurons [8].
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Two  different  GCs  catalyze  the  conversion  of  the
substrate guanosine ‘5-triphosphate into cGMP: particulate
(membrane-bound) GC (pGC) and soluble (cytosolic) GC
(sGC). sGC is activated by nitric oxide (NO). An increase in
retinal  tissue  levels  of  NO  using  the  NO  donor,  sodium
nitroprusside  (SNP),  results  in  the  induction  of  cGMP
immunoreactivity in amacrine, ganglion, and bipolar cells
[9,10].  pGCs  are  either  ligand-activated  receptors  (e.g.,
natriuretic peptides), or calcium-regulated guanylyl cyclase
[10]. In the turtle and rat retina, stimulation with exogenous
natriuretic peptides leads to an increase of total retinal cGMP
levels [10,11]. All three natriuretic peptides, atrial natriuretic
peptide,  brain  natriuretic  peptide,  and  C-type  natriuretic
peptide, have been observed in human ganglion and RPE cells
[12]. In situ hybridization techniques applied in monkey eyes
showed GC transcripts to be localized exclusively along the
retinal outer nuclear layer, which corresponded to the nuclei
of  the  rod  and  cone  photoreceptor  cells  [13].  Studies
describing both enzymatic pathways involved in the cGMP
production in the rat retina show that the NO-cGMP pathway
(via sGC) exists mainly in the inner nuclear layer, whereas the
ANP-cGMP pathway (via pGC) is predominantly present in
the  rod  photoreceptors  [10,11,14,15].  Cyclic  GMP  is
hydrolyzed to inactive 5′ –derivates by 3′, 5′- cyclic nucleotide
phosphodiesterases (PDEs) which have now been divided into
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25511 different subfamilies (PDE1-PDE11). The major function
for PDEs in the cell is to diminish the amplitude of the cyclic
nucleotide  second  messenger  signal  and  to  shorten  the
duration of its action [16].
The increased rate of fluid absorption from the subretinal
space indicates a possible role for cGMP in the clearance of
subretinal  fluid  after  retinal  detachment  [16].  The
involvement  of  cGMP  during  a  retinal  detachment  was
furthermore  suggested  by  a  previous  study,  in  which  we
observed a decreased level of cGMP in vitreous and subretinal
fluid of patients with retinal detachment [6]. Moreover, cGMP
levels decreased further as retinal detachment duration was
prolonged.
As  yet,  no  explanations  are  available  to  explain  the
decrease in cGMP concentration after retinal detachment. To
be able to address these questions , we found it necessary to
develop an experimental animal model. In this study we chose
the pig as the experimental animal because the size and the
physiology of the pig eye shows great resemblance to the
human eye.
METHODS
Retinal Detachments: Six Dutch domestic female pigs (Dutch
landrace; 28- 33 kg in weight; 3 months old) were used as
experimental  animals  (Varkensproefbedrijf,  Wageningen
UR, Lelystad, The Netherlands).
Unilateral retinal detachments were created in the right
eyes of six pigs. Animals were anesthetized by inhalation of
nitrous oxide and isoflurane. Via an entry site at the level of
the pars plana, between 0.1 and 0.5 ml of a solution of 0.25%
sodium  hyaluronate  (Pharmacia,Uppsala,Sweden)  was
slowly infused between the neural retina and RPE via a 20-
gauge subretinal canula attached to a 5 ml syringe.
During the infusion we visually checked perfusion of the
ophthalmic artery to assure that an intraocular pressure rise
would not result in arterial occlusion. Healon was used to
prevent spontaneous reattachment of the retina. All surgery
was done using an operating microscope and using similar
equipment for retinal surgery in the (human) clinical operating
room as described earlier [17]. After making an incision on
the temporal side of the optic disc, 0.25% sodium hyaluronate
was infused as described above, to create a retinal detachment
from the temporal side of the disk up to the midperiphery of
the retina, so that approximately one -third to half of the whole
retina was detached.
Approximately half the retina was detached in each eye.
By indirect ophthalmoscopy, we made sure that the retinas
remained  detached  for  the  duration  of  the  experiment.
Following surgery, the entry port was sutured closed, and
animals were given two times 250 mg acetazolamide daily for
the next three days to prevent intraocular pressure rise. The
left eyes were used as the control for all the experiments.
Following  14  days  of  detachment,  the  animals  were
euthanized  using  intravenous  pentobarbital  (200  mg/ml)
(Euthesate; Aesculaap, Boxtel, The Netherlands) and both
eyes were enucleated.
A period of 14 days was chosen since this was also a time
period whereby human patients showed a marked decrease in
their  intraocular  cGMP  levels  [6].  All  experimental
procedures conformed to the ARVO statement for the Use of
Animals  in  Ophthalmic  and  Vision  Research  and  the
guidelines of the Animal Resource Center of the University
of California Santa Barbara (Santa Barbara, CA).
Vitreous fluid collection: Vitreous fluid was obtained from
both eyes of six pigs, two weeks post experimental retinal
detachment.  Within  a  few  minutes  after  enucleation,
approximately 1.5 ml of vitreous fluid was aspirated from the
intact eye, using a syringe fitted with a 20 gauge needle. The
vitreous  sample  was  immediately  centrifuged,  and  the
supernatant was stored at −80 °C until tested for cGMP.
Cyclic GMP assay: Extracellular cGMP was measured in
duplicate using a commercially available ELISA kit (Assay
Designs,  Ann  Arbor,  MI).  We  used  100  μl  of  undiluted
vitreous fluid and performed the measurement according to
the manufacturer’s instructions. The amount of cGMP was
expressed as pmol/ml of undiluted vitreous. The sensitivity of
the cGMP assay was 0.088 pmol/ml.
Tissue Preparation: After enucleation and vitreous sampling,
an incision was made at the margin of the ora serrata to remove
the  lens  and  ciliary  body.  Subsequently  the  retina  was
removed, and randomly chosen small pieces were incubated
for 40 min in aerated Krebs buffer (pH 7.4) with or without
1  mM  IBMX,  a  nonspecific  PDE  inhibitor  (Sigma,
Amsterdam, The Netherlands). During the last ten minutes of
Figure 1. Effect of retinal detachment on vitreous cyclic guanosine
monophosphate (cGMP)(pmol/ml) levels. A retinal detachment was
induced in the right eyes of six pigs. Fourteen days later the eyes
were enucleated and vitreous from detached and non-detached eyes
was collected and analyzed for cGMP content with an immunoassay.
The figure shows the individual cyclic GMP levels in the eyes with
a detached or non-detached retina from each pig. It is clear that the
vitreous cGMP level in the eyes with a detached retina is lower that
that from the control eyes.
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256the incubation, the tissue was stimulated with 100 μM of the
NO donor SNP or 0.1 μM of the pGC stimulator ANP.
Immunohistochemistry:  To  determine  the  site  of  cGMP
production in the pig retina the following experiments were
performed. As mentioned in the previous paragraph, pieces of
retinal tissue from eyes with and without a retinal detachment
were incubated in vitro, and cGMP production was induced
by stimulation of the sGCs (by SNP) or pGCs (by ANP) with
a simultaneous inhibition of cGMP breakdown by PDEs using
IBMX. After incubation the retinal tissue pieces were fixed
with  4%  freshly  depolymerized  cold  (4  °C)
paraformaldehyde. Retina wholemounts were washed 3 times
for 5 min, twice with Tris-buffered saline (TBS) and once with
TBS containing 0.3% Triton X-100 (TBS-T). Samples were
subsequently incubated overnight at 4 °C with the primary
antibodies.  Cyclic  GMP  was  visualized  using  sheep
antiformaldehyde-fixed cGMP antiserum diluted 1:4000 in
TBS-T as we described earlier [18].
The following day, the samples were washed for 15 min
with  TBS  first,  then  TBS-T  and  TBS.  The  tissues  were
subsequently incubated with Alexa 488 conjugated donkey
antisheep IgG (Molecular Probes, Breda, The Netherlands),
diluted  1:100  in  TBS-T,  for  1.5  h  at  room  temperature.
Negative controls were processed in exactly the same way
with the omission of the primary antibody. The tissues were
washed three more washings in TBS, and the nuclei of the
cells were stained with Hoechst 33342, (Sigma, Zwijndrecht,
The Netherlands) for 20 min at room temperature (diluted
1:1000) and finally washed again in TBS. Wholemounts were
coverslipped with TBS:glycerol (1:2 v/v).
Microscopy:  Retinal  wholemounts  were  analyzed  by
fluorescence  microscopy  using  two-photon  laser  scanning
microscopy (TPLSM). TPLSM was performed as previously
described using a microscope objective (40x; water dipping;
numerical aperture [NA]=1.0) connected to an upright Nikon
E600FN  microscope  (Nikon  Corporation,  Tokyo,  Japan)
[19]. Further magnification, when needed, was achieved by
an optical zoom in the scan head. To remove background
noise,  we  filtered  each  image  using  the  Kalman  filtering
procedure on three subsequent images during experiments.
The fluorescent secondary antibody Alexa 488 was mainly
visible in the green channel, whereas Hoechst was only visible
in the red channel. The obtained images (coded green and red,
respectively) were combined into single images as needed.
Images were taken with a MBF Bioscience Stereo Investigator
Confocal Spinning Disk (SI-SD) system (MBF Bioscience,
Williston,  VT),  consisting  of  a  modified  Olympus  BX51
fluorescence  microscope  (Olympus,  Tokyo,  Japan)  with
UPlanSApo objectives, customized spinning disk unit (DSU;
Olympus,  Zoeterwoude,  The  Netherlands),  computer-
controlled excitation and emission filter wheels (Olympus),
three-axis high-accuracy computer-controlled stepping motor
specimen stage (4x4 Grid Encoded Stage; Ludl Electronic
Products,  Hawthorne,  NY),  linear  z-axis  position  encoder
(Ludl), ultra-high sensitivity monochrome electron multiplier
CCD camera (1,000x1,000 pixels, C9100–02; Hamamatsu
Photonics, Hamamatsu City, Japan) and controlling software
(MBF Bioscience). Pictures were taken in a single focal plane
with a 40x UPlanSApo objective (N.A.=0.9) and processed
with  Imaris  software  (Version  4.0;  Bitplane,  Zurich,
Switzerland).  Only  minor  adjustments  of  contrast  and
brightness were made without altering the appearance of the
original materials. No deconvolution was performed on the
images. The computer-based stereology system that was used
Figure 2. In vitro expression of cyclic guanosine monophosphate (cGMP) in the photoreceptor layer of a normal or detached pig retina. Small
pieces of retina were incubated with IBMX (a non-specific PDE inhibitor) and the particulate guanylyl cyclase (pGC) stimulator atrial
natriuretic peptide (ANP). The expression of cGMP (cGMP: green color) in the retina was then analyzed by immunohistochemistry and nuclei
were counterstained with Hoechst 33342 (red). Under these conditions no cGMP signal was visible in the photoreceptor layer of the healthy
retina (Panel A). The detached retina on the other hand displayed strong cGMP expression in the photoreceptor layer (Panels B and C). Panel
B is a double staining exposure for the nuclei and cGMP, showing the presence of cGMP in the nuclei of the cells (yellow) and in the cytoplasma
(green). In Panel C we only show the green signal, showing strong cGMP immunoreactivity in the same piece of retina. Scale bar represents
25 μm.
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257allows encoding of the Z-axis position thereby measuring the
actual focus position within the retina.
Statistical analysis: Because the cGMP values were paired
and nonparametric, we used the Wilcoxon signed ranks test
to compare the cGMP content in pig vitreous fluid of eyes with
and without retinal detachment. Differences were considered
significant when the p value was less than 0.05 (two-tailed).
RESULTS
We were able to detect cGMP in all the vitreous fluid samples
obtained from the pig eyes used in this study. The mean
vitreous level of cGMP was 1.45 pmol/ml (range: 0.09 to 4.32
pmol/ml)  in  eyes  with  retinal  detachment.  In  the  control
(contralateral) eyes, the mean vitreous level of cGMP was
4.61 pmol/ml (range between 0.40 to 14.10 pmol/ml). The
difference  in  vitreous  cGMP  levels  between  eyes  with
detached retinas and control eyes was significant (p=0.028 by
Wilcoxon signed ranks test). A large variation in cGMP levels
was observed between pigs. In each pig, however, the cGMP
level in the right eye with a retinal detachment was always
lower (between 1.6 and 5.8 times) than in the healthy left eye
(Figure 1).
Immunohistochemistry: The expression of cGMP in the
retina was analyzed by immunohistochemistry. No cGMP
expression could be observed in any of the retinal cells (either
detached or healthy) if phosphodieasterase activity had not
been blocked with IBMX. This indicates that under normal
conditions, cGMP has an extremely short half life. In the
absence of cyclase stimulation but in the presence of PDE
blockers, we observed cGMP immunoreactivity in the inner
nuclear layer of the detached as well as the healthy retinas.
Addition of 0.1 μM ANP as a stimulator of pGC, combined
with PDE inhibition, resulted in the appearance of a strong
cGMP signal in both the ganglion cells and the inner nuclear
layer of the healthy retina. No cGMP signal was visible in the
outer nuclear layer of the healthy retina (Figure 2A). The
detached retina on the other hand displayed strong cGMP
expression not only in the ganglion cells and the inner nuclear
layer but also in the outer nuclear layer (Figure 2B,C). Figure
2B shows both the nuclei of the cells (Hoechst staining; red
signal) and cGMP (green signal) staining of the outer nuclear
layer of a detached retina. Figure 2C only presents the green
signal, showing strong cGMP immunoreactivity in the same
piece  of  retina.  Following  stimulation  with  ANP  in  the
presence of IBMX, both the control eye and eye with the
detached retina showed cGMP-immunolabeling in the inner
and outer plexiform layer. Figure 3 presents the labeling of
the outer plexiform layer of a detached retina with Hoechst
(Figure 3A) and cGMP (Figure 3B) separately and together
(Figure 3C) in the same piece of retina. Incubating the retinas
in the presence of 100 μM SNP, as a stimulator of sGC in
combination with PDE inhibition (with IBMX) resulted in
cGMP-immunoreactivity  in  the  ganglion  cells,  the  inner
nuclear cell layer (Figure 4 C,D) and the nerve fiber layer of
the detached- and healthy retinas (Figure 4A,B). Stimulation
with SNP (+ IBMX) did not result in the appearance of cGMP
immunoreactivity in the photoreceptor cells of the detached
or healthy retina. Incubation of retinas with ANP or SNP (+
IBMX) both resulted in cGMP-immunoreactivity in the inner
nuclear layer, although not in all cell types (Figure 4C,D). The
aforedescribed experiments thus only showed a difference in
cGMP  expression  between  the  retinas  with  and  without
experimental detachment following in vitro stimulation of
pGC. In vitro, we demonstrated that ANP induced synthesis
of cGMP in the outer nuclear layer of the detached retina,
whereas this was not the case in the attached retina.
Figure 3. In vitro expression of cyclic guanosine monophosphate (cGMP) in the outer plexiform layer of a detached retina. Small pieces of
retina were incubated with IBMX (a non-specific PDE inhibitor) and the particulate guanylyl cyclase (pGC) stimulator atrial natriuretic peptide
(ANP). The expression of cGMP (cGMP: green color) in the retina was then analyzed by immunohistochemistry and nuclei were counterstained
with Hoechst 33342 (red). Following stimulation with ANP in the presence of IBMX, both the detached and healthy retina showed cGMP-
immunolabeling in the outer plexiform layer. Panel A shows the labeling of the outer plexiform layer of a detached retina with Hoechst. Panel
B shows the cGMP stain (green) of the outer plexiform layer probably representing photoreceptor axons and dendrites. Panel C is a double
staining exposure of the nuclei and cGMP. Scale bar represents 20 μm.
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258DISCUSSION
In the current study, we demonstrated the presence of cGMP
in pig vitreous fluid and showed a significantly lower vitreous
cGMP level following retinal detachment. The animal model
thus confirms earlier findings in humans in which we showed
a significantly lower vitreous cGMP concentration in patients
with an rhegmatogenous retinal detachment as compared to
controls [6]. Our findings are also in accordance with earlier
findings in a rabbit model that showed that vitreous cGMP
levels  were  almost  60%  lower  in  eyes  with  a  retinal
detachment than in control eyes [20].
Cyclic  GMP  production  is  catalyzed  by  either  sGC,
activated by NO or pGC stimulated by natriuretic peptides.
After retinal detachment, the activity of both sGC and pGC
could be reduced, since certain populations of retinal cells,
such as the photoreceptor or Mϋller cells, may have undergone
degenerative  changes  induced  by  hypoxic  or  ischemic
alterations  following  the  detachment  [4,5].  A  decreased
production of cGMP by retinal cells may concurrently lead to
a  lower  release  into  the  extracellular  space--in  this  case,
vitreous fluid. This explanation is speculative, however, since
no  evidence  is  available  to  date  concerning  extracellular
transport of cGMP from retinal cells. Previously we showed
that in vitro cultured RPE cells can be triggered to produce
and secrete cGMP into the culture medium [21]. A similar
approach could be used with retinal sections from healthy and
detached retinas to assess a possible contribution of sensory
retinal cells to the level of cGMP in vitreous or subretinal
fluids.
We measured cGMP in vitreous fluid and retinal sections
using  immunoassays.  The  presence  of  cGMP
immunoreactivity is considered to be equivalent to a potential
biologic activity of the cGMP molecule as we recently showed
in a model of rat aorta contraction and dilation [22]. Biologic
activity of cGMP depends on its targets, which include the
cGMP-dependent  protein  kinases,  cyclic  nucleotide-gated
channels, cAMP-dependent protein kinase, and PDEs [23].
The actual presence of these targets may differ among cells,
explaining the wide variety of activities of cGMP.
The cellular concentration of cGMP represents the net
balance  between  synthesis  by  guanylyl  cyclases  and
breakdown into 5′-cGMP by cyclic nucleotide PDEs [24]. The
decreased cGMP concentration in the vitreous after retinal
detachment could also be the result of increased PDE activity.
Figure 4. In vitro expression of c cyclic
guanosine  monophosphate  (cGMP)  in
the nerve fiber layer and inner nuclear
layer of a healthy or detached retina.
Small pieces of retina were incubated
with  IBMX  (a  non-specific  PDE
inhibitor)  and  the  soluble  guanylyl
cyclase  (sGC)  stimulator  sodium
nitroprusside (SNP). The expression of
cyclic GMP (cGMP: green color) in the
retina  was  analyzed  by
immunohistochemistry and nuclei were
counterstained  with  Hoechst  33342
(red). Panels A and B show a similar
cGMP expression in nerve fiber layer of
the normal (A) or detached (B) retina.
Panel  C  (normal  retina)  and  Panel  D
(detached retina) show cGMP staining
in the inner nuclear cells stained in red.
Scale bar represents 50 μm.
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259This seems less plausible, however, since no detectable PDE
activity  seems  to  be  present  in  vitreous  fluid  [6].  After
rhegmatogenous retinal detachment, vitreous passes through
a retinal break into the subretinal space and then comes into
direct contact with the RPE layer. It is possible that the cGMP
in the vitreous is degraded by PDEs located in the RPE cells.
This may be plausible since earlier studies have shown the
presence of at least PDE 2, PDE 5, and PDE 9 in RPE cells
[25].
Stimulation of sGC by the NO donor SNP resulted in
cGMP expression in the inner pig retina, especially in the
ganglion  cells  and  bipolar  cell  layer.  Further  studies  are
needed to determine the pathways that are targeted by cGMP
within these cells.
The effect of SNP on cGMP immunoreactivity in the pig
retina was similar to findings reported in other species [9,
10]. After stimulation of the particulate guanylyl cyclase with
ANP, cGMP expression was observed in the outer nuclear
layer  of  the  eyes  with  a  detached  retina.  Under  similar
conditions the outer nuclear layer of the eyes with a normal
attached retina did not express cGMP. The explanation for this
difference remains speculative. It may be caused by changes
in  local  PDE  levels  or  by  changes  in  the  ANP  receptor
expression of cells in the outer retina. Further analysis on
retinal PDE expression following detachment is necessary to
fully understand the dynamics of cGMP in the retina.
The increased cGMP expression in the detached retina
compared  with  the  normal  retina  seems  to  contradict  the
finding that cGMP levels were lower in the vitreous of eyes
with a detached retina. On the other hand this could also be
explained by assuming a decreased secretion of cGMP by the
retinal cells leading to lower levels in the extracellular space
and concomitant intracellular accumulation.
Most studies concerning retinal cGMP have focused on
its role in phototransduction [26]. Little is known about the
changes in cGMP expression in the retina and the vitreous
after  retinal  detachment.  It  has  been  shown  that  cGMP
stimulates subretinal fluid absorption whereas cAMP inhibits
this process [27]. Until now, we have only measured cGMP
in  ocular  fluids  following  clinical  or  experimental
detachments. Simultaneous determination of cAMP may be
useful for the understanding of subretinal fluid dynamics after
the formation of retinal break.
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